- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Carlsmed beruft Jenifer Kamocsay zur neuen Chief Legal Officer | 1 | Investing.com Deutsch | ||
| Mo | Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary | 105 | GlobeNewswire (Europe) | CARLSBAD, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions... ► Artikel lesen | |
| 22.09. | Carlsmed joins Russell 2000 Index following Q3 IPO | 1 | Seeking Alpha | ||
| 22.09. | Carlsmed, Inc. Selected for Inclusion in Russell 2000 Index | 1 | GlobeNewswire (USA) | ||
| 29.08. | Carlsmed stock rating reiterated at Buy by Goldman Sachs on growth outlook | 2 | Investing.com | ||
| 29.08. | Goldman Sachs bestätigt Kaufempfehlung für Carlsmed angesichts starker Wachstumsaussichten | 1 | Investing.com Deutsch | ||
| 29.08. | Carlsmed, Inc. Q2 Sales Increase | 1 | RTTNews | ||
| 28.08. | Carlsmed: Umsatz im zweiten Quartal 2025 fast verdoppelt, Aktie legt zu | 2 | Investing.com Deutsch | ||
| CARLSMED Aktie jetzt für 0€ handeln | |||||
| 28.08. | CARLSMED, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 28.08. | CARLSMED, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 28.08. | Carlsmed, Inc. reports Q2 results | 4 | Seeking Alpha | ||
| 28.08. | Carlsmed Reports Second Quarter 2025 Financial Results | 103 | GlobeNewswire (Europe) | Q2'25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M - $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" or the "Company")... ► Artikel lesen | |
| 18.08. | Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage | 2 | Benzinga.com | ||
| 18.08. | Carlsmed initiated with Buy at Truist on business potential | 2 | Seeking Alpha | ||
| 18.08. | Carlsmed stock initiated with Buy rating at BTIG on customized implant tech | 1 | Investing.com | ||
| 18.08. | BTIG startet Coverage für Carlsmed mit Kaufempfehlung - Potenzial bei personalisierter Implantat-Technologie | 1 | Investing.com Deutsch | ||
| 18.08. | Piper Sandler startet Coverage für Carlsmed mit 'Overweight' dank einzigartiger Implantat-Technologie | 2 | Investing.com Deutsch | ||
| 18.08. | Piper Sandler initiates Carlsmed stock with Overweight rating on custom implant potential | 2 | Investing.com | ||
| 18.08. | Goldman Sachs startet Coverage für Carlsmed mit Kaufempfehlung und Kursziel von 19 US-Dollar | - | Investing.com Deutsch | ||
| 18.08. | Goldman Sachs initiates coverage on Carlsmed stock with Buy rating | 1 | Investing.com |
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PRIVIA HEALTH GROUP | 24,460 | -2,08 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen | |
| GENEDX | 117,37 | 0,00 % | GeneDx announces first genomic newborn screening initiative | ||
| PROCEPT BIOROBOTICS | 34,800 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,045 | -4,61 % | Alignment Healthcare USA, LLC: Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors | ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 28,730 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 36,140 | 0,00 % | HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis | ||
| BETA BIONICS | 20,490 | +1,39 % | Forecasting The Future: 4 Analyst Projections For Beta Bionics | ||
| SIEMENS HEALTHINEERS | 47,030 | +0,26 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Die Ergebniserwartungen an das neue Geschäftsjahr... ► Artikel lesen | |
| AIRSCULPT TECHNOLOGIES | 7,960 | 0,00 % | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance | MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| MIMEDX | 6,710 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results | Highest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year Second Quarter GAAP Net Income and Diluted Earnings Per Share were $10 Million and $0.06... ► Artikel lesen | |
| RXSIGHT | 8,560 | 0,00 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
| PROGYNY | 20,540 | -3,20 % | A Healthcare Debate: Progyny vs. Hims & Hers | ||
| CLEARPOINT NEURO | 25,040 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System | New Product Category Will Enable Added Flexibility to Support Commercial Launches of Cell and Gene Therapy SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 83,00 | 0,00 % | Elutia closes $88M bioenvelope sale to Boston Scientific | ||
| GERRESHEIMER | 36,600 | 0,00 % | Community-Rückblick: wO User zu Gerresheimer AG Crash: "Die Bafin ist Teil des Problems!" | © Foto: Alex Kraus/Gerresheimer AG/dpaDie Gerresheimer Aktie crashte am Mittwoch, nachdem die BaFin eine Überprüfung des letzten Konzernabschlusses angekündigt hatte. Die Community diskutiert nun u.... ► Artikel lesen |
CARLSMED INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 13,370 Euro und damit +0,38 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CARLSMED INC finden Sie auf Wallstreet Online.